Introduction
A treatment once described as science fiction is now being tested in real patients, as researchers push tooth regeneration toward clinical reality.
The Treatment
Kyoto University Hospital has begun human trials of an antibody that targets USAG-1, a protein that normally suppresses tooth growth. By blocking USAG-1, researchers hope to trigger the growth of new teeth in patients missing some or all of their natural teeth.
Why It's a Big Deal
Current options for missing teeth, such as dentures and implants, are artificial replacements rather than biological regrowth. A working tooth-regrowth therapy could offer a fundamentally different approach to restorative dentistry.
Early-Stage Caution
As with any first-in-human trial, researchers are focused primarily on safety at this stage, with efficacy data expected to take longer to establish. Wider approval, if the therapy proves safe and effective, remains years away.
What It Could Mean
If successful, this approach could eventually reshape dental care for patients with congenital tooth loss or severe dental damage, offering a biological alternative to today's prosthetic solutions.
Kyoto Hospital Begins Human Trials of a Tooth-Regrowth Antibody
Tonerland Team • August 5, 2026 • 5 min read
An experimental treatment targeting the USAG-1 protein is being tested in patients as a potential alternative to dentures and implants.
Why It Matters
“ Power your business with innovation that works as hard as you do. Explore the new HP LaserJet Enterprise Series – only at Tonerland.
